Navigation Links
PDI Appoints Gerald R. Melillo, Jr. As SVP of Business Development
Date:10/10/2011

PARSIPPANY, N.J., Oct. 10, 2011 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced the appointment of Gerald R. Melillo, Jr. as senior vice president of Business Development, responsible for providing leadership and strategy to help drive PDI's commercial outsource services and contract sales business. He will report to Nancy Lurker, PDI's chief executive officer.

Melillo was most recently general manager of the Southeast Operating Unit for Novartis Pharmaceuticals Corporation, where he was accountable for the operating unit's commercial activities. From 2004 to 2008 at Novartis, he was vice president of the ABGIU Business Franchise, responsible for leading marketing and strategic planning for key in-line brands, multiple brand launches, and key partnerships and joint ventures.

"Gerry brings to PDI a wealth of experience in pharmaceutical industry sales and marketing, proven success in evaluating and closing business transactions, and keen insights into the goals and expectations of our pharmaceutical customers," said Lurker. "He is ideally equipped to lead our business development activities, and I'm confident that Gerry will play an integral role in PDI's future growth. We're delighted to have him aboard."

Melillo said, "PDI is a premier commercial outsource services provider, and I'm excited about joining at a time when pharmaceutical companies are looking to improve their promotional return on investment, reduce expenses and increase efficiency by integrating internal teams with outsourced sales teams. I look forward to working with Nancy and the rest of PDI to grow our market share in contract sales."

Prior to Novartis Pharmaceuticals, Melillo spent 15 years at Pharmacia, Inc. and a predecessor company, Upjohn, which merged with Pharmacia in 1997.

Melillo received a BS degree in Chemistry from Eckerd College, St. Petersburg, Fla.

About PDI, Inc.

PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise.  For more information, please visit the company's website at http://www.pdi-inc.com.


'/>"/>
SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive
2. SV Life Sciences Appoints Veteran Diagnostics Professional Dr. Heiner Dreismann as Venture Partner
3. Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
4. CIVCO Appoints Andres Ramirez Sales Director of Advanced Robotics and Workflow Solutions
5. Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors
6. Tengion Appoints Scott Flora to Board of Directors
7. AcelRx Pharmaceuticals Appoints Mark G. Edwards To Its Board of Directors
8. China Medicine Corporation Appoints PricewaterhouseCoopers As Independent Auditor To Audit Results For Fiscal Years 2006 - 2010
9. ImpactRx Appoints Anand Narasimhan Executive Vice President, Operations and Technology
10. Jazz Pharmaceuticals Appoints Head of Research and Development
11. diaDexus Appoints New CEO Brian E. Ward, Ph.D. and New CBO Michael Richey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):